(Q34082086)

30 July 2017

title

Intravitreal triamcinolone versus laser photocoagulation as a primary treatment for diabetic macular oedema--a comparative pilot study (English)

1 reference

30 July 2017

1 reference

3

1 reference

30 July 2017

4

1 reference

30 July 2017

Mustapha Norlaili

1

1 reference

30 July 2017

Shaharuddin Bakiah

series ordinal

2

1 reference

30 July 2017

publication date

23 November 2011

1 reference

30 July 2017

1 reference

30 July 2017

volume

11

1 reference

30 July 2017

page(s)

36

1 reference

https://scigraph.springernature.com/pub.10.1186/1471-2415-11-36

30 July 2017

exact match

0 references

cites work

Comparison of photocoagulation with combined intravitreal triamcinolone for diabetic macular edema

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

A randomized, placebo-controlled clinical trial of intravitreal triamcinolone for refractory diabetic macular edema.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal triamcinolone plus sequential grid laser versus triamcinolone or laser alone for treating diabetic macular edema: six-month outcomes.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal triamcinolone for diffuse diabetic macular oedema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Modified grid laser photocoagulation versus pars plana vitrectomy with internal limiting membrane removal in diabetic macular edema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal injection of triamcinolone: an emerging treatment for diabetic macular edema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Intravitreal injection of triamcinolone for diffuse diabetic macular edema

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Treatment with intravitreal steroid reduces blood-retinal barrier breakdown due to retinal photocoagulation

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

Agreement of the Heidelberg Retina Tomograph II macula edema module with fundus biomicroscopy in diabetic maculopathy.

28 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Intravitreal triamcinolone as a primary therapy in diabetic macular oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Intravitreal triamcinolone for diabetic macular oedema in Chinese patients: six-month prospective longitudinal pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Relation between reduction of foveal thickness and visual acuity in diabetic macular edema treated with intravitreal triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Regression of serous macular detachment after intravitreal triamcinolone acetonide in patients with diabetic macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2415-11-36

Intravitreal triamcinolone acetonide injection as primary treatment for diabetic macular edema

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3231950

28 October 2018

Identifiers

DOI

10.1186/1471-2415-11-36

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference

30 July 2017

1 reference